Dentium Co., Ltd. (145720) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Dentium Co., Ltd. (145720:KRX), powered by AI.

Current Price
₩51,000
P/E Ratio
6.0
Market Cap
564.5B
Sector
Healthcare
What is the Dentium Co., Ltd. stock price forecast?

Dentium Co., Ltd. is currently trading at ₩51,000. View real-time AI analysis on Alpha Lenz.

What is Dentium Co., Ltd. insider trading activity?

View the latest insider trading data for Dentium Co., Ltd. on Alpha Lenz.

What is Dentium Co., Ltd.'s P/E ratio?

Dentium Co., Ltd.'s P/E ratio is 6.0.

Dentium Co., Ltd.

₩51.00K
KRX145720
Ask about Dentium Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Dentium Co., Ltd. trades at a P/E of 6.0 (undervalued) with solid ROE of 14.3%. 3Y revenue CAGR of 11.8% highlights clear growth momentum.

Ask for details

Company Overview

Dentium Co., Ltd. is a prominent player in the global dental industry, primarily focusing on the design, development, and manufacture of dental products. Specializing in dental implant systems, the company provides a comprehensive range of solutions, including surgical kits, prosthetic devices, and related dental instruments. Widely recognized for its commitment to quality and innovation, Dentium serves dental professionals and clinics across various regions, facilitating advanced dental care and procedural efficiency. With state-of-the-art manufacturing facilities and rigorous quality control, Dentium has established a reputation for high standards and reliability in dental healthcare. Its role in the market is significant, as it not only enhances dental treatment options but also contributes to the broader healthcare ecosystem through research, development, and education. Dentium's dedication to improving patient outcomes and modernizing dental practices underpins its important place within the evolving dental industry landscape.

CEO서승우, 윤병호
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees835

Company Statistics

(FY 2024)

Profile

Market Cap₩564.51B
Revenue₩407.81B
Shares Out11.07M
Employees835

Margins

Gross63.82%
EBITDA35.19%
Operating24.15%
Pre-Tax23.03%
Net17.76%

Valuation

P/E6.05
P/B0.79
EV/Sales1.08
EV/EBITDA4.15
P/FCF29.70

Growth (CAGR)

Rev 3Yr11.84%
Rev 5Yr10.05%
Op Inc 3Yr11.97%
Op Inc 5Yr17.13%
Net Inc 3Yr9.27%
Net Inc 5Yr39.49%

Returns

ROA8.68%
ROE14.27%
ROIC12.41%

Financial Health

Cash & Cash Equivalents₩99.61B
Net Debt₩241.31B
Debt/Equity61.59%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Dentium Co., Ltd. (Healthcare) Stock Forecast & Analysis ₩51,000 | Alpha Lenz